Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: A randomised controlled trial

Archives of Disease in Childhood

Volumn 92, Issue 6, 2007, Pages 499-501

  Gittins, Nicola S ^a   Hunter Blair, Yan L ^b   Matthews, John N S ^c   Coulthard, Malcolm G ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; UROKINASE;

ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASCULAR PATENCY; VENOUS THROMBOSIS;

EID: 34249867456     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.100065     Document Type: Article

References (7)

1. Twadorski ZJ. The clotted central vein catheter for haemodialysis. Nephrol Dial Transplant 1998;13:2203-6.
2. Bamgbola OF, del Rio M, Kaskel FJ, et al. Recombinant tissue plasminogen activator infusion for haemodialysis catheter clearance. Pediatr Nephrol 2005;20:989-93.
3. Coulthard MG, Sharp J. Haemodialysing infants: theoretical limitations, and single versus double lumen lines. Pediatr Nephrol 2001;16:332-4.
4. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research, 4th ed. Oxford: Blackwell, 2002.
5. Davis SN, Vermeulen L, Banton J, et al. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices. Am J Health Syst Pharm 2000;57(11):1039-45.
6. Calis KA, Cullinane AM, Horne MK 3rd. Bioactivity of cryopreserved alteplase solutions. Am J Health Syst Pharm 1999;56(20):2056-7.
7. Vanholder R. Vascular access: care and monitoring of function. Nephrol Dial Transplant 2001;16:1542-5.